<DOC>
	<DOC>NCT00902772</DOC>
	<brief_summary>The purpose of this study is to examine the abuse potential of AZD7325.</brief_summary>
	<brief_title>Study to Evaluate the Abuse Potential of AZD7325 in Healthy Recreational Central Nervous System (CNS) Depressant Users</brief_title>
	<detailed_description />
	<mesh_term>Lorazepam</mesh_term>
	<mesh_term>Central Nervous System Depressants</mesh_term>
	<criteria>Recreational CNS depressant use, defined as at least 10 lifetime occasions of nonmedical use of drugs with depressant/sedative properties and at least 1 nonmedical use in the year prior to screening Body mass index (BMI) within the range of 19.0 to 33.0 kg/m2, inclusive, and a minimum weight of 50.0 kg at screening Willing and able to abide by all study requirements and restrictions Unwillingness of inability to abstain from recreational drug use for the duration of the study from screening until followup Positive breath alcohol test prior to dosing Clinically significant abnormalities on physical examination, medical history, 12lead ECG, vital signs, or safety laboratories</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Recreational CNS depressant</keyword>
	<keyword>Abuse liability</keyword>
	<keyword>Abuse potential</keyword>
	<keyword>Healthy Recreational CNS Depressant Users</keyword>
</DOC>